Innate immune responses support adaptive immunity: NKT cells induce B cell activation

Vaccine

Volumn 21, Issue SUPPL. 2, 2003, Pages

  Galli, Grazia ^a   Nuti, Sandra ^a   Tavarini, Simona ^a   Galli Stampino, Luisa ^a   De Lalla, Claudia ^b   Casorati, Giulia ^b   Dellabona, Paolo ^b   Abrignani, Sergio ^a  

^a CHIRON VACCINES   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Helper activity; NKT; Galactosylceramide

Indexed keywords

CD1D ANTIGEN;

ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; BIODIVERSITY; CELL ACTIVATION; CELL INTERACTION; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNITY; MOLECULAR RECOGNITION; NATURAL KILLER CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0038632120     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(03)00200-7     Document Type: Article

References (40)

1. McDonald H.R. Development and selection of NKT cells. Curr. Opin. Immunol. 14:2002;250-254.
2. Kronenberg M., Gapin L. The unconventional lifestyle of NKT cells. Nat. Rev. Immunol. 2:2002;557-568.
3. Gumperz J.E., Miyake S., Yamamura T., Brenner M.B. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J. Exp. Med. 5:2002;625-650.
4. Lee P.T., Benlagha K., Teyton L., Bendelac A. Distinct functional lineages of human Vα24 natural killer T cells. J. Exp. Med. 5:2002;637-641.
5. + T cells. Development, specificity, and function. Annu. Rev. Immunol. 15:1997;535-562.
6. Godfrey D.I., Hammond K.J.L., Poulton L.D., Smyth M.J., Baxter A.J. NKT cells: facts functions and fallacies. Immunol. Today. 21:2000;573-583.
7. - T cells. J. Exp. Med. 180:1994;1171-1176.
8. Davodeau F., Peyrat M.A., Necker A.et al. Close phenotypic and functional similarities between human and murine αβ T cells expressing invariant TCR α chains. J. Immunol. 158:1997;5603-5611.
9. - T cells in mice and humans. J. Exp. Med. 180:1994;1097-2106.
10. Benlagha K., Bendelac A. CD1d-restricted mouse Vα14 and human Vα24 T cells: lymphocyte of innate immunity. Semin. Immunol. 12:2000;537-542.
11. + NKT lymphocytes are activated memory cells. Eur. J. Immunol. 30:2000;1544-1550.
12. Matsuda J.L., Naidenko O.V., Gapin L.et al. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 192:2000;741-754.
13. Carnaud C., Lee D., Donnaris O.et al. Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J. Immunol. 163:1999;4647-4650.
14. Singh N., Hong S., Scherer D.C.et al. Activation of NK T cells by CD1d and α-galactosylceramide directs conventional T cells to the acquisition of Th2 phenotype. J. Immunol. 163:1999;2373-2377.
15. Hong S., Wilson M.T., Serizawa I.et al. The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat. Med. 9:2001;1052-1056.
16. Miyamoto K., Miyake S., Yamamura T. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing Th2 bias of natural killer T cells. Nature. 413:2001;531-534.
17. Gumperz J.E., Brenner M.B. CD1-specific T cells in microbial immunity. Curr. Opin. Immunol. 13:2001;471-478.
18. Smyth M.J., Crowe N.Y., Hayakawa Y., Takeda K., Yagita H., Godfrey D.I. NKT cells - conductors of tumor immunity? Curr. Opin. Immunol. 14:2002;165-171.
19. + T lymphocytes. Science. 268:1995;863-865.
20. - T cells. J. Exp. Med. 186:1997;109-120.
21. Porcelli S.A., Modlin R.L. The CD1d system: antigen presenting molecules for T cell recognition of lipids and glycolipids. Annu. Rev. Immunol. 17:1999;297-329.
22. Kawano T., Cui J., Koezuka Y., Toura I.et al. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science. 278:1997;1626-1629.
23. Spada F.M., Koezuka Y., Porcelli S.A. CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells. J. Exp. Med. 188:1998;1529-1534.
24. Brossary L., Chioda M., Burdin N.et al. CD1d-mediated recognition of an α-galactosylceramide by natural killer cells is highly conserved through mammalian evolution. J. Exp. Med. 188:1998;1521-1528.
25. + T cells in a Th2 response and in immunoglobulin E production. Science. 270:1995;1845-1847.
26. Scoefield L., McConville M.J., Hansen D.et al. CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells. Science. 283:1999;225-229.
27. Molano A., Park S.H., Chiu Y.H., Dossier S., Bendelac A., Tsuji M. The IgG response to the circumsporozoite protein is MHC class II-dependent and CD1d-independent: exploring the role of GPIs in NKT cell activation and antimalarial responses. J. Immunol. 164:2001;5005-5009.
28. Assenmacher M., Schmitz J., Radbruch A. Flow cytometric determination of cytokines in activated murine lymphocytes: expression of IL-10 in interferon-γ and interleukin 4 expressing cells. Eur. J. Immunol. 24:1994;1097-1101.
29. Lyons A.B. Analyzing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. J. Immunol. Methods. 243(1-2):2000;147-154.
30. Agematsu K., Hokibara S., Nagumo H., Komiyama A. CD27: a memory B cell marker. Immunol. Today. 21:2000;204-206.
31. Lanzavecchia A. Antigen-specific interaction between T and B cells. Nature. 314:1985;537-539.
32. Krieg A.M. CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 20:2002;709-760.
33. Kim C.H., Johnston B., Butcher E.C. Trafficking machinery of NKT cells: shared and differential chemokine receptor expression among Vα24(+) Vβ11(+) NKT cell subsets with distinct cytokine producing capacity. Blood. 100:2002;11-16.
34. MacLennan I.C.M. Germinal centers. Annu. Rev. Immunol. 12:1994;117-139.
35. Cyster J.G. Chemokines and cell migration in secondary lymphoid organs. Science. 286:1999;2098-2102.
36. Kim H.J., Krenn V., Steinhauser G., Berek C. Plasma cell development in synovial germinal centers in patients with rheumatoid and reactive arthritis. J. Immunol. 162:1999;3053-3062.
37. Murakami J., Shimizu Y., Kashii Y.et al. Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C. Hepatology. 30:1999;143-150.
38. Cui J., Watanabe N., Kawano T.et al. Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-activated Vα14 natural killer cells. J. Exp. Med. 190:1999;783-792.
39. Burdin N., Brossay L., Kronenberg M. Immunization with α-galactosylceramide polarizes CD1-reactive NKT cells towards Th2 cytokine synthesis. Eur. J. Immunol. 29:1999;2014-2025.
40. Hayakawa Y., Takeda K., Yagita H., Van Kaer L., Saiki I., Okumura K. Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways. J. Immunol. 166:2001;6012-6018.